UK Global Cancer Network aims to enhance cancer care in LMICs
The UK Global Cancer Network (UK GCN) is an independent non-profit network of UK-based individuals and institutions working in partnership […]
Read More
Articles by Author: habiba
Author: habiba
Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer
While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to […]
Read MoreVariations in a gene and a protein aggravate the prognosis of one gastric tumour
Low plasma levels of protein TGFB1 and polymorphisms in gene TGFB1 act as biomarkers for the prognosis of gastric adenocarcinoma, […]
Read MoreWhite button mushrooms could slow progression of prostate cancer
The chemicals present in white button mushrooms may slow the progression of prostate cancer, according to a mouse study presented […]
Read MoreResistance-busting ICR drug enters clinical trial
A drug discovered at The Institute of Cancer Research, London, that could counteract drug resistance in patients with cancers including […]
Read MoreLung cancer resistance: the key is glucose
Cancers are not only made of tumour cells. In fact, as they grow, they develop an entire cellular ecosystem within […]
Read MoreELCC 2021: More than one in 10 patients with lung cancer do not know what type they have
More than one in 10 patients with lung cancer do not know what type of tumour they have, according to […]
Read MoreCommon drugs for type 2 diabetes and obesity do not increase breast cancer risk
Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated […]
Read MoreStudy estimates rising global burden of gallbladder and biliary tract cancer
Although cancers that occur in the gallbladder or bile ducts are rare, their rates are increasing. A recent study provides […]
Read MoreProstate cancer uses metabolic switch to thrive after hormone therapy
Studying the cellular metabolism of prostate cancer, a team of Duke Health-led researchers identified a key reason hormone therapies eventually […]
Read More